clinical study in improvement of quality of life in cancer patients with ayurvedic medicine

clinical evaluation of amritha bhallathaka rasayana in improvement of quality of life in cancer patients - qol in cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008042

Enrollment

Registered

2017-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CANCER PATIENTS

Interventions

Intervention1: Amrithabhallathaka rasayana: Dose 6 gms twice a day after food with milk for 6 months Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: • The patients between the age group of 25-65 years of either sex and who are Cancer affected will be include in the study. • Kernoffsky performance status >70%.

Exclusion criteria

Exclusion criteria: •Acute or Chronic Leukaemias. • Female patients who are pregnant or breastfeeding. • Acute or chronic liver disease. • Confirmed diagnosis of HIV,Tuberculosis. • Patients not responding to regular therapy. • Patients who are in terminal ill condition. • Patients having other Chronic systemic illness.

Design outcomes

Primary

Measure	Time frame
improve the QOL in cancer patients.Timepoint: improve the QOL in cancer patients.	—

Secondary

Measure	Time frame
SafetyTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDrAKarunakara Rao

Dr. N.R.S. Govt.Ayurvedic College

drkarunakar09@gmail.com9052407909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026